GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA1A, AKR1B1, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, FLT3, HCAR2, HTR2A, HTR2B, HTR6, KDR, MET, MMP12, MMP9, PTPN1, SRC, TERT, XDH |
9.50065 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA1A, AKR1B1, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, FLT3, HCAR2, HTR2A, HTR2B, HTR6, KDR, MET, MMP12, MMP9, PTPN1, SRC, TERT, XDH |
9.50065 |
[BP] GO:0042221 |
response to chemical
|
ADRA1A, AKR1B1, ALPL, APEX1, APP, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, FABP3, FABP4, FLT3, HSD17B2, HTR2A, HTR2B, HTR5A, IGF1R, KDR, MMP2, MMP9, POLB, PPARA, RORC, SRC, TERT, TOP1, TYR |
9.01743 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRA1A, AKR1B1, APEX1, APP, AURKB, AXL, BCL2, CA12, CA2, CA7, CHRM1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, FABP3, FABP4, FLT3, HCAR2, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR7, KDR, MET, POLA1, POLB, PPARA, SRC, TERT, XDH |
9.01743 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APEX1, APP, AXL, BCL2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, FABP3, HSD17B2, HTR5A, IGF1R, MMP2, MMP9, POLB, PPARA, RORC, SRC, TYR |
8.7254 |
[BP] GO:0007187 |
None
|
ADORA1, ADRA1A, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, HTR1A, HTR5A, HTR6, HTR7 |
8.39602 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA1A, AKR1B1, APP, BCL2, CDC25B, CHRM1, CSNK2A1, CYP1B1, DRD2, DRD3, F3, FABP3, FLT3, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, SRC, TERT, XDH |
8.15776 |
[BP] GO:0007193 |
None
|
ADORA1, CHRM1, CHRM2, CHRM4, DRD2, DRD3, HTR1A, HTR5A, HTR7 |
8.04605 |
[BP] GO:0007188 |
None
|
ADORA1, ADRA1A, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, HTR1A, HTR5A, HTR7 |
7.95874 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TYR |
7.91868 |
[BP] GO:0010033 |
response to organic substance
|
ADRA1A, AKR1B1, ALPL, APEX1, APP, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, FABP3, FABP4, FLT3, HSD17B2, HTR5A, IGF1R, KDR, MMP2, POLB, PPARA, RORC, SRC, TYR |
7.8668 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APEX1, APP, BCL2, CHRM1, CHRM4, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, IGF1R, KDR, MET, MMP9, SRC, TERT |
7.57814 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, ALPL, APEX1, APP, AURKB, AXL, BCL2, CA2, CA9, CHRM2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, F10, F3, FABP3, FABP4, FLT3, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, IGF1R, KDR, MMP12, MMP2, MMP9, POLA1, POLB, PPARA, PTPN1, RORC, SRC, TERT, TOP1, TOP2A, TYR |
7.5166 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APEX1, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, FLT3, HTR5A, RORC, SRC, TYR |
7.28546 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA1A, AKR1B1, APEX1, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, FABP3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
7.25072 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APEX1, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, KDR, MMP9, SRC, TERT |
7.23542 |
[BP] GO:0042493 |
response to drug
|
ADRA1A, AKR1B1, APEX1, AXL, BCL2, CA9, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, FABP3, HTR2A, HTR2B, KDR, POLB, SRC, TOP1 |
7.23197 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALPL, APEX1, APP, AURKB, AXL, BCL2, CA2, CA9, CDC25B, CHRM1, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, FABP4, FLT3, FUT7, GLO1, HSD17B2, HTR2A, HTR2B, HTR5A, KDR, MET, MMP2, MMP9, PIM1, POLB, PPARA, RORC, SIGMAR1, SRC, TERT, TOP2A, TYR |
7.23197 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA1A, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AXL, BCL2, CHRM1, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, F10, F3, FABP4, HSD17B2, HTR1A, HTR2A, HTR2B, HTR7, IGF1R, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, RORC, SRC, TOP1, TYR |
6.94864 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA1A, AKR1B1, APEX1, APP, AXL, BCL2, CA12, CA2, CA7, DRD1, DRD2, DRD3, FABP3, FABP4, FLT3, HTR2A, HTR2B, MET, POLA1, POLB, SRC, TERT |
6.94864 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.94864 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, DRD1, DRD2, DRD3, HTR2A, HTR2B, KDR, SRC |
6.94864 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, CHRM1, CSNK2A1, DRD2, DRD3, F3, FLT3, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, TERT |
6.94864 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, F3, FLT3, GLO1, HCAR2, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SIGMAR1, SRC, TERT, TOP2A, XDH |
6.94864 |
[BP] GO:0007210 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.94864 |
[BP] GO:0098664 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.94864 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA1A, AKR1B1, APP, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, F10, F3, FLT3, HTR2A, HTR2B, HTR6, KDR, MET, MMP12, MMP9, PTPN1, SRC, TERT, XDH |
6.92283 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, F3, FLT3, GLO1, HCAR2, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SIGMAR1, SRC, TERT, TOP2A, XDH |
6.89676 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, APEX1, APP, AXL, BCL2, CA2, CA7, CHRM1, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, HCAR2, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, SRC, TERT |
6.74935 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APP, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD2, FABP3, FABP4, FUT7, HSD17B1, HSD17B2, MET, PPARA, TBXAS1 |
6.42396 |
[BP] GO:0007200 |
None
|
ADRA1A, CHRM1, CHRM2, CHRM4, DRD1, DRD2, HTR2A, HTR2B |
6.42396 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA1A, AKR1B1, APP, AXL, BCL2, CYP1B1, DRD2, F10, F3, FLT3, HTR2A, HTR2B, HTR6, KDR, MET, PTPN1, SRC, XDH |
6.34979 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, F3, FLT3, GLO1, HCAR2, HTR2B, IGF1R, KDR, MMP9, PIM1, PTPN1, SIGMAR1, SRC, TERT, TOP2A, XDH |
6.25973 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APEX1, APP, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, IGF1R, KDR, MET, MMP9, SRC, TERT |
6.22195 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, KDR, POLB, SRC |
6.1688 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRA1A, AKR1B1, APEX1, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, FABP3, FABP4, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
6.12006 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, FUT7, GLO1, HTR2B, PIM1, PPARA, TBXAS1, TYR, XDH |
5.94908 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
5.94908 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APEX1, APP, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, IGF1R, KDR, MET, MMP9, SRC, TERT |
5.84817 |
[BP] GO:0003018 |
None
|
ADORA1, ADRA1A, CHRM1, DRD1, HTR1A, HTR2A, HTR2B, HTR7, SRC |
5.80483 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APEX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, F10, F3, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HTR1A, HTR2B, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, POLA1, POLB, PPARA, PTPN1, RORC, SRC, TBXAS1, TERT, TOP1, TOP2A, TYR, XDH |
5.78024 |
[BP] GO:0097756 |
None
|
ADORA1, ADRA1A, HTR1A, HTR2A, HTR2B, HTR7 |
5.75549 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DRD2, DRD3, HTR7, PPARA, RORC, SRC, TOP1, TOP2A |
5.7357 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA1A, AKR1B1, ALPL, APEX1, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A2, DRD1, FABP3, FLT3, HTR5A, IGF1R, MMP2, PPARA, SRC |
5.55315 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA1A, AKR1B1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, F10, F3, FLT3, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP9, PTPN1, SRC, XDH |
5.50459 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA1A, AKR1B1, APP, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP12, MMP9, PTPN1, SRC, TERT, XDH |
5.50459 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, DRD1, DRD2, DRD3, HTR2A, HTR2B, MMP2, POLB, PPARA, SRC, TERT, TYR |
5.44832 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD1, DRD2, DRD3, HTR1A, TYR |
5.42312 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, BCL2, CA2, CA7, DRD1, DRD2, DRD3, HCAR2, HTR2A, HTR2B, KDR, SRC |
5.41177 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA1A, AKR1B1, APP, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP12, MMP9, PTPN1, SRC, TERT, XDH |
5.40167 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APEX1, APP, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, IGF1R, KDR, MET, MMP9, SRC, TERT |
5.40167 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA1A, AKR1B1, APP, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, F10, F3, FABP4, FLT3, HTR2A, HTR2B, HTR6, KDR, MET, MMP12, MMP2, MMP9, PTPN1, SRC, TERT, XDH |
5.37906 |
[BP] GO:0097746 |
None
|
ADORA1, ADRA1A, CHRM1, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
5.37906 |
[BP] GO:0035296 |
None
|
ADORA1, ADRA1A, CHRM1, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
5.37906 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, ADRA1A, APP, CA2, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, SIGMAR1, SRC |
5.32866 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, HSD17B1, HSD17B2 |
5.29462 |
[BP] GO:0006939 |
None
|
ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7 |
5.29462 |
[BP] GO:0050880 |
None
|
ADORA1, ADRA1A, CHRM1, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
5.19161 |
[BP] GO:0035150 |
None
|
ADORA1, ADRA1A, CHRM1, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
5.17094 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, HTR1A, TYR |
5.1629 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, GLO1, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TERT |
5.0719 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, FABP3, FLT3, HSD17B2, HTR5A, RORC, SRC, TYR |
5.0719 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, APEX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, F10, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HTR1A, HTR2B, IGF1R, KDR, MET, MMP1, MMP2, PIM1, POLA1, POLB, PPARA, PTPN1, RORC, SRC, TBXAS1, TERT, TOP1, TOP2A, TYR, XDH |
4.99933 |
[BP] GO:0003013 |
None
|
ADORA1, ADRA1A, CHRM1, DRD1, HTR1A, HTR2A, HTR2B, HTR7, SRC |
4.91343 |
[BP] GO:0042310 |
None
|
ADRA1A, HTR1A, HTR2A, HTR2B, HTR7 |
4.87071 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, GLO1, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SRC, TERT |
4.84635 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, DRD3, FABP3, FLT3, HCAR2, HTR2A, HTR2B, PPARA, RORC, SRC |
4.8047 |
[BP] GO:0009725 |
response to hormone
|
ADRA1A, AKR1B1, ALPL, APEX1, BCL2, CA2, CA9, CSNK2A1, CYP1A2, FABP3, FLT3, HTR5A, PPARA, SRC |
4.73292 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, ADRA1A, CA2, CA7, DRD2 |
4.66256 |
[BP] GO:0050795 |
None
|
ADORA1, DRD2, DRD3, HTR1A, HTR2A, HTR2B |
4.61177 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, ADRA1A, APP, CA2, CA7, DRD1, DRD2, DRD3, HTR2A |
4.58163 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, ADRA1A, APP, CA2, CA7, DRD1, DRD2, DRD3, HTR2A |
4.58163 |
[BP] GO:0007198 |
None
|
HTR1A, HTR5A, HTR7 |
4.43173 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.43173 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA1A, AKR1B1, APP, AXL, BCL2, CA1, CA2, CHRM1, CHRM2, CHRM4, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP2, MMP9, PIM1, POLB, PPARA, PTPN1, RORC, SIGMAR1, SRC |
4.41036 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALPL, APP, AXL, BCL2, CA2, CHRM1, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, FLT3, HSD17B2, HTR5A, KDR, MMP9, PIM1, POLB, PPARA, RORC, SIGMAR1, SRC, TYR |
4.36579 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, DRD2, HCAR2, HSD17B1, HSD17B2, HTR1A, HTR2A |
4.29171 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, APP, AXL, BCL2, CA2, CHRM1, CYP19A1, DRD1, DRD2, DRD3, HCAR2, HTR2B, MMP12, SRC, TERT |
4.29171 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, ADRA1A, APP, CA2, CA7, DRD1, DRD2 |
4.27614 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, FABP3, PPARA |
4.25466 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD1, DRD2, DRD3, HTR1A |
4.24158 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, GLO1, HTR2B, IGF1R, KDR, MMP9, PIM1, PTPN1, SRC, TERT |
4.21097 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, APP, AXL, BCL2, CA2, CA7, CHRM1, CYP19A1, DRD1, DRD2, DRD3, HCAR2, HTR1A, HTR2A, HTR2B, MMP12, MMP9, PPARA, PTPN1, SRC, TERT |
4.18953 |
[BP] GO:0007197 |
None
|
CHRM1, CHRM2, CHRM4 |
4.09511 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, AKR1B10, ALOX5, ALPL, APEX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CHRM1, CHRM2, CHRM4, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, F10, F3, FABP3, FABP4, FLT3, FUT7, GLO1, HCAR2, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, POLA1, POLB, PPARA, PTPN1, RORC, SIGMAR1, SRC, TBXAS1, TERT, TOP1, TOP2A, TYR, XDH |
4.09511 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, SRC |
4.08563 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, BCL2, DRD1, F10, F3, IGF1R, KDR, MET, MMP9, SRC, TERT |
4.05058 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CHRM1, CSNK2A1, CYP1A1, CYP1A2, CYP2D6, DRD1, DRD2, DRD3, F10, F3, FLT3, FUT7, GLO1, HTR1A, HTR2B, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, POLB, PPARA, PTPN1, SRC, TOP1, TOP2A, TYR, XDH |
4.04168 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, BCL2, CHRM1, CHRM4, CYP1A1, FLT3, HTR1A, MET, PIM1, POLA1, SRC, TYR |
4.01929 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALPL, APEX1, APP, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, POLA1, POLB, PTPN1, RORC, SRC, TERT, TOP2A |
3.91934 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, BCL2, DRD1, F10, F3, IGF1R, KDR, MET, MMP9, SRC, TERT |
3.91886 |
[BP] GO:0048148 |
None
|
DRD1, DRD2, DRD3, HTR2A |
3.91734 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT |
3.90842 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, APEX1, APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, FLT3, HTR2B, IGF1R, KDR, MET, PIM1, POLB, PTPN1, SRC, TOP1, XDH |
3.84336 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, APEX1, APP, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, DRD1, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, RORC, SRC, TERT |
3.83983 |
[BP] GO:0007207 |
None
|
CHRM1, CHRM2, CHRM4 |
3.83917 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, DRD3, F10, F3, MET, SRC, XDH |
3.82679 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, BCL2, DRD1, F10, F3, IGF1R, KDR, MET, MMP9, SRC, TERT |
3.82233 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, MMP2, POLB, PPARA, SRC, TERT |
3.79315 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, FLT3, HTR2B, IGF1R, KDR, MET, PIM1, SRC, TOP1 |
3.79312 |
[BP] GO:0007268 |
None
|
CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7 |
3.79312 |
[BP] GO:0098916 |
None
|
CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7 |
3.79312 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA1A, AKR1B1, APP, BCL2, CA12, CA2, CA7, DRD1, DRD2, DRD3, FABP3, FABP4, HTR2A, HTR2B, MET |
3.75352 |
[BP] GO:0099536 |
None
|
CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7 |
3.71696 |
[BP] GO:0099537 |
None
|
CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7 |
3.71696 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, BCL2, DRD1, F10, F3, IGF1R, KDR, MET, MMP9, SRC, TERT |
3.69955 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TBXAS1 |
3.69 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, APEX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA7, CA9, CDC25B, CHRM1, CHRM2, CHRM4, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, F10, F3, FABP3, FABP4, FLT3, GLO1, HCAR2, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, POLA1, POLB, PPARA, PTPN1, RORC, SIGMAR1, SRC, TERT, TOP1, TOP2A, XDH |
3.68192 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA1A, APP, AXL, BCL2, CA2, CYP1B1, DRD2, DRD3, F3, HCAR2, HTR2A, HTR2B, KDR, MET, MMP12, MMP9, PIM1, SRC, TERT |
3.67538 |
[BP] GO:0042752 |
None
|
ADORA1, DRD2, DRD3, PPARA, RORC, TOP2A |
3.67538 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6, TBXAS1 |
3.67371 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD2, FABP3, FABP4, FUT7, MET, PPARA, TBXAS1 |
3.66958 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, APP, BCL2, CDC25B, DRD1, DRD2, FABP3, FLT3, HTR2A, HTR2B, KDR, MMP9, PTPN1, SRC, XDH |
3.66015 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA1A, APP, BCL2, CDC25B, DRD1, DRD2, FABP3, FLT3, HTR2A, HTR2B, KDR, MMP9, PTPN1, SRC, XDH |
3.66015 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.65634 |
[BP] GO:0032922 |
None
|
DRD2, DRD3, PPARA, RORC, TOP1 |
3.65047 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, APEX1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, FABP3, FABP4, GLO1, HTR2A, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
3.65047 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, APP, BCL2, CA2, CA7, CHRM1, DRD1, DRD2, DRD3, HTR1A, HTR2A, MMP9 |
3.63004 |
[BP] GO:0007568 |
aging
|
ADRA1A, APEX1, AURKB, BCL2, CYP1A1, HTR2A, POLB, TERT |
3.60471 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, APEX1, APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, FLT3, HTR2B, IGF1R, KDR, MET, PIM1, POLB, PTPN1, SRC, TOP1, XDH |
3.59295 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TBXAS1 |
3.55696 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA1A, APP, DRD2, FLT3, HTR2A, HTR2B, KDR, PTPN1, SRC, XDH |
3.55585 |
[BP] GO:0010038 |
response to metal ion
|
APP, BCL2, CA2, CYP1A1, CYP1A2, DRD2, FABP4, MMP9, TERT |
3.54115 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA1A, APP, BCL2, CDC25B, DRD1, DRD2, DRD3, FABP3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
3.53931 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, APP, BCL2, CDC25B, DRD1, DRD2, DRD3, FABP3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
3.49119 |
[BP] GO:0051940 |
None
|
DRD1, DRD2, DRD3 |
3.49119 |
[BP] GO:0051584 |
None
|
DRD1, DRD2, DRD3 |
3.49119 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, SRC |
3.48435 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2 |
3.48435 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
3.48435 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, APP, DRD1, DRD2, DRD3, FABP3, FLT3, IGF1R, MMP2, PPARA, SRC, TYR |
3.42739 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APEX1, APP, AURKB, AXL, BCL2, CDC25B, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, F10, F3, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HTR1A, HTR2B, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, POLA1, POLB, PPARA, PTPN1, RORC, SRC, TBXAS1, TERT, TOP1, TOP2A, TYR, XDH |
3.41733 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, MMP9, SRC |
3.40879 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CSNK2A1, CYP1B1, CYP2D6, DRD2, DRD3, FABP4, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC |
3.39533 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, HSD17B1, HSD17B2, TBXAS1, TYR, XDH |
3.38527 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, DRD1, DRD2, HTR2A |
3.37428 |
[BP] GO:0071073 |
None
|
FABP3, HTR2A, HTR2B |
3.34346 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, FABP3, PPARA |
3.32973 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, BCL2, CYP2D6, MET, MMP9, PPARA, SRC, TERT |
3.3263 |
[BP] GO:0048513 |
animal organ development
|
ACHE, ADRA1A, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, FLT3, HSD17B2, KDR, POLB, PPARA, SRC, TYR |
3.31514 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, DRD2, MMP2, PPARA, SRC, TERT |
3.29388 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, DRD1, DRD2, HTR2A, MET |
3.29212 |
[BP] GO:0001659 |
None
|
ADORA1, DRD1, DRD2, HTR2A |
3.27047 |
[BP] GO:0050801 |
ion homeostasis
|
ADRA1A, APP, BCL2, CA12, CA2, CA7, DRD1, DRD2, DRD3, FABP3, HTR2A, HTR2B |
3.27047 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2 |
3.26139 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APEX1, APP, CYP1A1, CYP1B1, DRD1, FLT3, RORC, SRC |
3.26138 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA1A, APP, BCL2, CDC25B, DRD1, DRD2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
3.26005 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.21531 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, MMP2, PPARA, SRC, TERT |
3.21509 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, PPARA, SRC |
3.20612 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, APEX1, APP, AXL, BCL2, CYP1A1, CYP1B1, DRD1, FABP4, FLT3, IGF1R, KDR, MMP2, RORC, SRC |
3.20275 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA1A, APP, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, F3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
3.20275 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APEX1, APP, AURKB, AXL, BCL2, CDC25B, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, F10, F3, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HTR2B, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, POLA1, POLB, PPARA, PTPN1, RORC, SRC, TBXAS1, TERT, TOP1, TOP2A, TYR, XDH |
3.19859 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, SRC |
3.16176 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ADRA1A, APP, BCL2, CDC25B, DRD2, FLT3, HTR2A, HTR2B, KDR, MMP9, PTPN1, SRC, XDH |
3.15695 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADRA1A, APP, BCL2, CDC25B, DRD1, DRD2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, MMP9, PTPN1, SRC, XDH |
3.15695 |
[BP] GO:0090068 |
positive regulation of cell cycle process
|
APEX1, APP, AURKB, CDC25B, CYP1A1, DRD2, DRD3, TERT |
3.1525 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ADRA1A, APP, DRD2, HTR2A, HTR2B, KDR, PTPN1, SRC |
3.1525 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, APP, DRD1, DRD2, DRD3, FABP3, FLT3, IGF1R, MMP2, PPARA, SRC, TYR |
3.12978 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
3.12978 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, APEX1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, FABP3, FABP4, GLO1, HCAR2, HTR2A, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
3.12362 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ADRA1A, APP, DRD2, HTR2A, HTR2B, KDR, SRC |
3.11955 |
[BP] GO:0002031 |
None
|
DRD2, DRD3, HTR2B |
3.1108 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APEX1, APP, AURKB, CDC25B, CYP1A1, DRD2, DRD3, SRC, TERT |
3.10652 |
[BP] GO:0021885 |
forebrain cell migration
|
AXL, DRD1, DRD2, HTR6 |
3.10158 |
[BP] GO:0050789 |
regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, APEX1, APP, AURKB, AXL, BCL2, CA1, CA2, CA7, CA9, CDC25B, CHRM1, CHRM2, CHRM4, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, F10, F3, FABP3, FABP4, FLT3, GLO1, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, POLA1, POLB, PPARA, PTPN1, RORC, SIGMAR1, SRC, TERT, TOP1, TOP2A, XDH |
3.10158 |
[BP] GO:0051952 |
None
|
ADORA1, DRD1, DRD2, DRD3, HTR2A |
3.07353 |
[BP] GO:0050794 |
regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, APEX1, APP, AURKB, AXL, BCL2, CA1, CA2, CA7, CA9, CDC25B, CHRM1, CHRM2, CHRM4, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, F10, F3, FABP3, FABP4, FLT3, GLO1, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, POLA1, POLB, PPARA, PTPN1, RORC, SIGMAR1, SRC, TERT, TOP2A, XDH |
3.02247 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, HCAR2, HTR2B, MMP12, SRC |
3.02025 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ADRA1A, APP, DRD2, FLT3, HTR2A, HTR2B, IGF1R, KDR, PTPN1, SRC, XDH |
3.02025 |
[BP] GO:0032467 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
3.01886 |
[BP] GO:0007623 |
circadian rhythm
|
DRD2, DRD3, HTR7, PPARA, RORC, TOP1 |
3.00899 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRA1A, APP, BCL2, CDC25B, DRD2, FLT3, HTR2A, HTR2B, KDR, MMP9, PTPN1, SRC, XDH |
2.98355 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA1A, BCL2, DRD1, DRD2, DRD3, HTR2A, IGF1R, MET, MMP12, MMP9, PTPN1, SRC, TERT, XDH |
2.96717 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, PPARA, TBXAS1 |
2.95417 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA1A, BCL2, DRD1, DRD2, DRD3, HTR2A, IGF1R, MET, MMP12, MMP9, PTPN1, SRC, TERT, XDH |
2.95417 |
[BP] GO:0030534 |
None
|
APP, DRD1, DRD2, DRD3, HTR2A, PPARA |
2.94943 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRA1A, AKR1B1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, FABP4, FLT3, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP12, MMP2, MMP9, PPARA, PTPN1, SRC, TERT, XDH |
2.94428 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, BCL2, DRD2, DRD3, HTR2A, MMP9 |
2.93631 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRA1A, APP, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, F3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, MMP9, PTPN1, SRC, TERT, XDH |
2.93631 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.92647 |
[BP] GO:0060134 |
None
|
DRD1, DRD2, DRD3 |
2.92647 |
[BP] GO:0032230 |
positive regulation of synaptic transmission, GABAergic
|
ADRA1A, CA2, CA7 |
2.92647 |
[BP] GO:0007154 |
None
|
ADORA1, ADRA1A, AXL, BCL2, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7 |
2.92647 |
[BP] GO:0006286 |
base-excision repair, base-free sugar-phosphate removal
|
APEX1, POLB |
2.92282 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, FLT3, HTR2B, IGF1R, KDR, MET, PIM1, SRC, TOP1 |
2.91439 |
[BP] GO:0051781 |
None
|
AURKB, CDC25B, DRD2, DRD3, HTR2B |
2.91439 |
[BP] GO:1901989 |
None
|
APEX1, APP, CDC25B, CYP1A1, TERT |
2.91439 |
[BP] GO:0045931 |
positive regulation of mitotic cell cycle
|
APEX1, APP, CDC25B, CYP1A1, DRD3, TERT |
2.90754 |
[BP] GO:0032845 |
None
|
ADORA1, BCL2, DRD2, HTR2A, HTR2B, SRC |
2.90754 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, DRD1, F10, FLT3, IGF1R, KDR, MET, SRC, TOP1, TOP2A |
2.89366 |
[BP] GO:0007267 |
None
|
ADORA1, ADRA1A, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7 |
2.88125 |
[BP] GO:0045776 |
None
|
ADORA1, DRD2, DRD3, PPARA |
2.84661 |
[BP] GO:0051580 |
None
|
DRD1, DRD2, DRD3 |
2.84554 |
[BP] GO:0051967 |
None
|
ADORA1, DRD2, HTR2A |
2.84554 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
ADRA1A, BCL2, DRD2, DRD3, IGF1R, MET, MMP9, PTPN1, SRC, XDH |
2.84398 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA1A, APP, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, F3, FABP3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
2.83112 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA1A, APP, AURKB, BCL2, CDC25B, DRD1, DRD2, DRD3, F3, FABP3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
2.82375 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD1, DRD2, DRD3, HCAR2 |
2.8194 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD1, DRD2, DRD3 |
2.8194 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD1, DRD2, DRD3 |
2.8194 |
[BP] GO:2001023 |
None
|
DRD1, DRD2, DRD3, HTR2A, MET |
2.81663 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA1A, APP, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, F3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
2.81395 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
ADRA1A, APP, BCL2, CA12, CA2, CA7, DRD1, DRD2, DRD3, HTR2A, HTR2B |
2.80065 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRA1A, AKR1B1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, F10, F3, FLT3, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP12, MMP9, PTPN1, SRC, TERT, XDH |
2.78433 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, FABP4, FUT7, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
2.78433 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3 |
2.78433 |
[BP] GO:0019933 |
None
|
ADRA1A, DRD1, DRD2, DRD3, HTR5A |
2.77988 |
[BP] GO:0001963 |
None
|
DRD1, DRD2, DRD3 |
2.7738 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TBXAS1 |
2.76061 |
[BP] GO:0019932 |
second-messenger-mediated signaling
|
ADRA1A, DRD1, DRD2, DRD3, HTR2B, HTR5A, KDR |
2.72729 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, ADRA1A, APP, AURKB, BCL2, CDC25B, CSNK2A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, F3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TERT, XDH |
2.71744 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ADRA1A, APEX1, APP, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, F3, FABP3, FABP4, FLT3, GLO1, HCAR2, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, PIM1, POLA1, PPARA, PTPN1, RORC, SRC, TERT, TOP1, TOP2A, XDH |
2.71715 |
[BP] GO:0019725 |
cellular homeostasis
|
ADRA1A, APEX1, APP, BCL2, CA2, CA7, DRD1, DRD2, DRD3, HTR2A, HTR2B, POLA1 |
2.71296 |
[BP] GO:0035556 |
intracellular signal transduction
|
ADRA1A, AKR1B1, AXL, BCL2, CYP1B1, DRD1, DRD2, DRD3, HTR2A, HTR2B, HTR5A, IGF1R, KDR, MET, POLB, PTPN1, SRC |
2.70276 |
[BP] GO:0071071 |
None
|
FABP3, HTR2A, HTR2B |
2.69953 |
[BP] GO:0007213 |
None
|
CHRM1, CHRM2, CHRM4 |
2.69953 |
[BP] GO:0032225 |
None
|
DRD1, DRD2, DRD3 |
2.69953 |
[BP] GO:0003014 |
None
|
ADORA1, ADRA1A, AKR1B1, BCL2, DRD2 |
2.6853 |
[BP] GO:0008542 |
None
|
APP, DRD1, DRD2, DRD3 |
2.66075 |
[BP] GO:0003008 |
None
|
ADORA1, ADRA1A, AKR1B1, APP, BCL2, CHRM1, CYP1B1, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR7, SRC, TYR |
2.64105 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, HTR1A, MMP2, MMP9, POLA1, POLB, PPARA, PTPN1, SRC, TERT, TOP2A |
2.61887 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6, TBXAS1 |
2.61077 |
[BP] GO:0019935 |
None
|
ADRA1A, DRD1, DRD2, DRD3, HTR5A |
2.61077 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, HCAR2, HTR1A, HTR2A, HTR2B, MMP12, SRC |
2.59718 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, APP, CA2, CHRM1, DRD2, DRD3, HCAR2, HTR2B, MMP12, PTPN1, SRC |
2.59704 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APEX1, APP, AXL, BCL2, CYP1B1, MMP9, SRC |
2.59072 |
[BP] GO:0030003 |
cellular cation homeostasis
|
ADRA1A, APP, BCL2, CA2, CA7, DRD1, DRD2, DRD3, HTR2A, HTR2B |
2.56032 |
[BP] GO:0014821 |
None
|
DRD1, DRD2, HTR2B |
2.56032 |
[BP] GO:0002793 |
None
|
ACHE, ADORA1, DRD2, HCAR2, HTR2B, MMP12, SRC |
2.53571 |
[BP] GO:0098502 |
DNA dephosphorylation
|
APEX1, POLB |
2.5332 |
[BP] GO:0060160 |
None
|
DRD2, DRD3 |
2.5332 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.5332 |
[BP] GO:0023052 |
None
|
ADORA1, ADRA1A, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7 |
2.52243 |
[BP] GO:0007632 |
None
|
APP, DRD1, DRD2, DRD3 |
2.51699 |
[BP] GO:0045187 |
None
|
ADORA1, DRD2, DRD3 |
2.5005 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.5005 |
[BP] GO:0016477 |
cell migration
|
AXL, CYP1B1, DRD1, DRD2, FUT7, HTR2B, HTR6, KDR, MMP1, MMP12, MMP9, SRC |
2.5005 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
2.4953 |
[BP] GO:0006873 |
cellular ion homeostasis
|
ADRA1A, APP, BCL2, CA2, CA7, DRD1, DRD2, DRD3, HTR2A, HTR2B |
2.48959 |
[BP] GO:0002521 |
leukocyte differentiation
|
AXL, BCL2, FLT3, FUT7, GLO1, MMP9, RORC |
2.48959 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, BCL2, CYP1A1, DRD2, PPARA |
2.4654 |
[BP] GO:0031623 |
None
|
ACHE, DRD2, DRD3, HTR2B |
2.46497 |
[BP] GO:0003012 |
None
|
ADORA1, ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7 |
2.46255 |
[BP] GO:0030336 |
None
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD2 |
2.45361 |
[BP] GO:0035813 |
None
|
ADORA1, DRD2, DRD3 |
2.44845 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA1A, APP, AXL, BCL2, CA2, CHRM1, CHRM2, CYP1B1, DRD2, DRD3, F3, HCAR2, HTR2A, HTR2B, KDR, MET, MMP12, MMP9, PIM1, SRC, TERT, XDH |
2.42823 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
2.41094 |
[BP] GO:0006811 |
None
|
ADRA1A, CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD1, DRD2, DRD3, FABP3, HTR2A, HTR2B, PPARA |
2.40927 |
[BP] GO:0090066 |
None
|
ADORA1, ADRA1A, CHRM1, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
2.40808 |
[BP] GO:0032787 |
None
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, GLO1, PPARA, TBXAS1 |
2.4045 |
[BP] GO:0050890 |
None
|
ADORA1, APP, CHRM1, DRD1, DRD2, DRD3, HTR2A |
2.39637 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.39531 |
[BP] GO:0042749 |
None
|
ADORA1, DRD2, DRD3 |
2.39531 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.39531 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6, RORC |
2.39222 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, DRD1, DRD2, HTR2A |
2.37009 |
[BP] GO:0070988 |
demethylation
|
APEX1, CYP1A1, CYP1A2, CYP2D6 |
2.37009 |
[BP] GO:0051046 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, HCAR2, HTR1A, HTR2A, HTR2B, MMP12, SRC |
2.36698 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.36514 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA1A, BCL2, CYP19A1, DRD1, DRD2, DRD3, IGF1R, MET, MMP12, MMP9, PPARA, PTPN1, SRC, TERT, XDH |
2.34559 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.34373 |
[BP] GO:2000146 |
None
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD2 |
2.33369 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
ADRA1A, APP, BCL2, DRD1, DRD2, DRD3, HTR2A, HTR2B |
2.33142 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1 |
2.32589 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD17B1, HSD17B2 |
2.32589 |
[BP] GO:0040011 |
locomotion
|
AXL, CYP1B1, DRD1, DRD2, FUT7, HTR2B, HTR6, KDR, MET, MMP1, MMP12, MMP9, SRC |
2.32589 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CYP1B1, DRD1, KDR, SRC |
2.32099 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
2.31443 |
[BP] GO:0032880 |
regulation of protein localization
|
ACHE, APP, BCL2, CHRM1, CSNK2A1, DRD2, DRD3, HCAR2, HTR2B, MMP12, PTPN1, SRC, TERT |
2.31403 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR |
2.30906 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
2.30657 |
[BP] GO:0095500 |
None
|
CHRM1, CHRM2, CHRM4 |
2.30657 |
[BP] GO:0044062 |
None
|
ADORA1, DRD2, DRD3 |
2.30657 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.30657 |
[BP] GO:1903831 |
None
|
CHRM1, CHRM2, CHRM4 |
2.30657 |
[BP] GO:0009416 |
response to light stimulus
|
APP, AURKB, BCL2, DRD1, DRD2, DRD3, TYR |
2.30657 |
[BP] GO:1903522 |
None
|
ADORA1, ADORA3, ADRA1A, CHRM1, CHRM2, DRD2, HTR2A |
2.30657 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.304 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APEX1, APP, AXL, CYP1B1, DRD1, IGF1R, MMP2, MMP9, RORC, SRC |
2.29299 |
[BP] GO:0055080 |
cation homeostasis
|
ADRA1A, APP, BCL2, CA2, CA7, DRD1, DRD2, DRD3, HTR2A, HTR2B |
2.2665 |
[BP] GO:0060402 |
None
|
ADRA1A, DRD2, HTR2A, HTR2B |
2.2665 |
[BP] GO:0055074 |
calcium ion homeostasis
|
ADRA1A, APP, BCL2, DRD1, DRD2, DRD3, HTR2A, HTR2B |
2.26498 |
[BP] GO:0007202 |
None
|
ADRA1A, HTR2A, HTR2B |
2.25986 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.25986 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
2.24763 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.24763 |
[BP] GO:0006940 |
None
|
ADORA1, ADRA1A, CHRM1, CHRM2 |
2.24763 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
ADRA1A, APP, BCL2, DRD1, DRD2, DRD3, HTR2A, HTR2B |
2.23439 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ADRA1A, APP, BCL2, CDC25B, DRD2, FLT3, HTR2A, HTR2B, KDR, MMP9, PTPN1, SRC, XDH |
2.22735 |
[BP] GO:0050878 |
regulation of body fluid levels
|
ADORA1, AKR1B1, CHRM1, DRD2, F10, F3, MET, XDH |
2.22404 |
[BP] GO:0051271 |
None
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD2 |
2.22404 |
[BP] GO:1904951 |
positive regulation of establishment of protein localization
|
ACHE, APP, BCL2, CHRM1, DRD2, HCAR2, HTR2B, MMP12, SRC |
2.22404 |
[BP] GO:0014910 |
regulation of smooth muscle cell migration
|
APEX1, BCL2, SRC, TERT |
2.20717 |
[BP] GO:0040014 |
regulation of multicellular organism growth
|
APP, BCL2, DRD2, DRD3 |
2.20717 |
[BP] GO:0015908 |
None
|
DRD2, DRD3, FABP3, PPARA |
2.20717 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, ADRA1A, CHRM1, CHRM2, DRD2, DRD3, HCAR2, HTR2A |
2.20341 |
[BP] GO:0048870 |
cell motility
|
AXL, CYP1B1, DRD1, DRD2, FUT7, HTR2B, HTR6, KDR, MMP1, MMP12, MMP9, SRC |
2.19664 |
[BP] GO:0032465 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
2.18564 |
[BP] GO:0001975 |
None
|
DRD1, DRD2, DRD3 |
2.17299 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, DRD3, F3, FABP4, KDR, MET, MMP12, PPARA |
2.17 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, GLO1 |
2.16449 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
ADRA1A, APP, BCL2, CA2, CA7, DRD1, DRD2, DRD3, HTR2A, HTR2B |
2.15617 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, APP, CDC25B, DRD2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, PTPN1, SRC |
2.14604 |
[BP] GO:1901992 |
positive regulation of mitotic cell cycle phase transition
|
APEX1, APP, CYP1A1, TERT |
2.14604 |
[BP] GO:0007416 |
None
|
ACHE, APP, DRD1, DRD2 |
2.14604 |
[BP] GO:0030198 |
extracellular matrix organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.1373 |
[BP] GO:0006936 |
None
|
ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7 |
2.1373 |
[BP] GO:0007271 |
None
|
CHRM1, CHRM2, CHRM4 |
2.1373 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
APEX1, APP, AURKB, BCL2, CDC25B, CYP1A1, DRD3, PIM1, TERT, TOP2A |
2.1373 |
[BP] GO:0043062 |
extracellular structure organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.1373 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, ADRA1A, APP, AURKB, BCL2, CDC25B, DRD2, F3, FLT3, HTR2A, HTR2B, MET, MMP9, PTPN1, SRC, TERT, XDH |
2.1373 |
[BP] GO:0008306 |
None
|
APP, DRD1, DRD2, DRD3 |
2.1373 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.1373 |
[BP] GO:0098501 |
polynucleotide dephosphorylation
|
APEX1, POLB |
2.1373 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.1373 |
[BP] GO:0007598 |
None
|
F10, F3 |
2.1373 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.1373 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.1373 |
[BP] GO:0090325 |
None
|
DRD2, DRD3 |
2.1373 |
[BP] GO:0010513 |
None
|
HTR2A, HTR2B |
2.1373 |
[BP] GO:0040013 |
None
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD2 |
2.13588 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
ADRA1A, APP, BCL2, DRD1, DRD2, DRD3, HTR2A, HTR2B |
2.12998 |
[BP] GO:0007189 |
None
|
ADRA1A, DRD1, DRD2, DRD3 |
2.1202 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ALPL, APP, AXL, BCL2, CDC25B, CYP1A1, DRD1, DRD2, FABP4, FLT3, FUT7, GLO1, HTR2B, KDR, MET, MMP2, MMP9, RORC, SRC, TERT, TOP2A |
2.11986 |
[BP] GO:0007610 |
None
|
APP, BCL2, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, PPARA |
2.10945 |
[BP] GO:0042417 |
None
|
DRD1, DRD2, DRD3 |
2.10945 |
[BP] GO:0014059 |
None
|
DRD2, DRD3, HTR2A |
2.10945 |
[BP] GO:0009314 |
response to radiation
|
APP, AURKB, BCL2, DRD1, DRD2, DRD3, POLB, TYR |
2.10939 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.10358 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, ADRA1A, APP, AURKB, BCL2, CDC25B, DRD2, F3, FLT3, HTR2A, HTR2B, PTPN1, SRC, TERT, XDH |
2.09278 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ADRA1A, APP, BCL2, CDC25B, DRD1, DRD2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, MMP9, PTPN1, SRC, XDH |
2.07487 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, ADRA1A, APEX1, APP, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, F3, FABP3, FABP4, FLT3, GLO1, HCAR2, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, PIM1, POLA1, PPARA, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
2.07232 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, MMP2, MMP9, TERT |
2.04119 |
[BP] GO:0060401 |
None
|
ADRA1A, DRD2, HTR2A, HTR2B |
2.04119 |
[BP] GO:0051302 |
None
|
AURKB, CDC25B, DRD2, DRD3, HTR2B |
2.03248 |
[BP] GO:0035265 |
organ growth
|
ADRA1A, BCL2, CYP19A1 |
2.03054 |
[BP] GO:0002209 |
None
|
BCL2, DRD1, HTR1A |
2.03054 |
[BP] GO:0001662 |
None
|
BCL2, DRD1, HTR1A |
2.03054 |
[BP] GO:0070201 |
None
|
ACHE, APP, BCL2, CHRM1, DRD2, DRD3, HCAR2, HTR2B, MMP12, PTPN1, SRC |
2.02265 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, ADRA1A, APEX1, APP, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, F3, FABP3, FABP4, FLT3, GLO1, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, PIM1, POLA1, PPARA, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
2.0219 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, APEX1, APP, AURKB, BCL2, CSNK2A1, CYP2D6, DRD2, DRD3, FABP4, HCAR2, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, TERT, XDH |
2.02135 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ADRA1A, APP, BCL2, CDC25B, CSNK2A1, DRD2, F3, FLT3, HTR2A, HTR2B, KDR, MMP9, PTPN1, SRC, XDH |
2.01439 |
[BP] GO:0050730 |
None
|
ADORA1, APP, FLT3, HTR2A, PTPN1, SRC |
2.00115 |
[BP] GO:0014065 |
phosphatidylinositol 3-kinase signaling
|
HTR2A, HTR2B, IGF1R |
2.00115 |
[BP] GO:0045744 |
None
|
DRD2, DRD3, MET |
2.00115 |
[BP] GO:0010039 |
response to iron ion
|
BCL2, CYP1A1, DRD2 |
2.00115 |
[BP] GO:0021843 |
None
|
DRD1, DRD2 |
2.00115 |
[BP] GO:0051902 |
negative regulation of mitochondrial depolarization
|
BCL2, SRC |
2.00115 |
[BP] GO:0021830 |
None
|
DRD1, DRD2 |
2.00115 |
[BP] GO:0021826 |
None
|
DRD1, DRD2 |
2.00115 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP2D6 |
2.00115 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, APP, AXL, CA4, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, F10, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1 |
7.69956 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, APP, AXL, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1 |
6.07547 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ADRA1A, ALPL, APP, AXL, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM4, CSNK2A1, DRD1, DRD2, DRD3, F10, F3, FLT3, GLO1, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP2, PIM1, PTPN1, SRC, TERT |
5.49855 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, ADRA1A, APP, AXL, CA2, CA4, CA9, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, F10, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1, SRC |
4.87862 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ADRA1A, ALOX5, ALPL, APP, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM4, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, F10, F3, FLT3, FUT7, GLO1, HCAR2, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP2, PIM1, PTPN1, SIGMAR1, SRC, TBXAS1, TERT, TYR |
4.35243 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ADRA1A, ALPL, APP, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM4, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, F10, F3, FLT3, FUT7, HCAR2, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PTPN1, SIGMAR1, SRC, TBXAS1, TYR |
3.65047 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, ADRA1A, CA2, CA4, CA9, CHRM1, CHRM2, CHRM4, DRD1, DRD2, HTR2A, MET, SIGMAR1, SRC |
3.02247 |
[CC] GO:0009330 |
None
|
TOP1, TOP2A |
2.92282 |
[CC] GO:0005783 |
None
|
ADORA1, APEX1, APP, BCL2, CA4, CYP19A1, CYP2D6, FLT3, HTR5A, KDR, PTPN1, SIGMAR1, XDH |
2.62711 |
[CC] GO:0031224 |
None
|
ACHE, ADORA1, ADORA3, ADRA1A, ALPL, APP, AXL, CA12, CA14, CA4, CA9, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, F10, F3, FLT3, FUT7, HCAR2, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1, TBXAS1, TYR |
2.53524 |
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.44845 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, F10, FLT3, HSD17B2, PTPN1, SIGMAR1, TBXAS1 |
2.00115 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
2.00115 |
[MF] GO:0008227 |
None
|
ADRA1A, CHRM1, CHRM2, CHRM4, DRD2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
11.6596 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPL, APEX1, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, F10, F3, FABP3, FABP4, FLT3, GLO1, HSD17B1, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, POLA1, POLB, PPARA, PTPN1, RORC, SRC, TBXAS1, TERT, TOP1, TOP2A, TYR, XDH |
10.9708 |
[MF] GO:0030594 |
None
|
CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
10.4826 |
[MF] GO:0099528 |
None
|
CHRM1, CHRM2, CHRM4, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
10.2873 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, GLO1, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, TBXAS1, TYR, XDH |
10.1157 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
9.86136 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, APEX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, F10, GLO1, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, MMP1, MMP12, MMP2, MMP9, PIM1, POLA1, POLB, PPARA, PTPN1, RORC, TBXAS1, TERT, TOP2A, TYR, XDH |
8.73091 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, AXL, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PPARA, RORC, SIGMAR1 |
8.15776 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
8.15776 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, POLB |
8.07473 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, F10, F3, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, POLA1, POLB, PTPN1, SRC, TBXAS1, TERT, TOP1, TOP2A, TYR, XDH |
7.69956 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRA1A, AXL, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1 |
7.5166 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, AXL, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1 |
7.5166 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA1A, AXL, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PPARA, RORC, SIGMAR1 |
7.28546 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CHRM1, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MET, PIM1, PPARA, SIGMAR1, SRC, TOP1, TOP2A |
7.16556 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA1A, AXL, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PPARA, RORC, SIGMAR1 |
7.08187 |
[MF] GO:0004993 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.94864 |
[MF] GO:0099589 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.94864 |
[MF] GO:0043176 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
6.9441 |
[MF] GO:0051378 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
6.9441 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA1A, AXL, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PPARA, RORC, SIGMAR1 |
6.63634 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.36647 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, GLO1, POLB |
6.34407 |
[MF] GO:0004930 |
None
|
ADORA1, ADORA3, ADRA1A, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, SIGMAR1 |
5.52156 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
5.33812 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
5.09968 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
5.09109 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TBXAS1, TYR |
4.92085 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TBXAS1, XDH |
4.61545 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, HSD17B1, HSD17B2, TBXAS1, TYR, XDH |
4.25552 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, SRC, TBXAS1 |
4.13205 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, APEX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, F10, GLO1, MMP1, MMP12, MMP2, MMP9, PIM1, POLA1, POLB, PPARA, PTPN1, RORC, TBXAS1, TERT, TOP2A, TYR, XDH |
4.10003 |
[MF] GO:0016907 |
None
|
CHRM1, CHRM2, CHRM4 |
4.09511 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
3.99831 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, SRC, TBXAS1 |
3.94549 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, GLO1, MMP1, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC |
3.79312 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TBXAS1, TYR |
3.67538 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.42837 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, HSD17B1, POLA1, SRC, TBXAS1, XDH |
3.03354 |
[MF] GO:0004952 |
None
|
DRD1, DRD2, DRD3 |
3.00948 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.00899 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, APEX1, CSNK2A1, FLT3, HTR2A, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SRC |
2.99151 |
[MF] GO:0035240 |
None
|
DRD1, DRD2, DRD3 |
2.92647 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, APEX1, FLT3, HTR2A, IGF1R, KDR, MMP12, MMP9, PPARA, PTPN1, SRC |
2.6849 |
[MF] GO:0015464 |
None
|
CHRM1, CHRM2, CHRM4 |
2.56032 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.44845 |
[MF] GO:1901338 |
None
|
DRD1, DRD2, DRD3 |
2.44845 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, POLA1, POLB, SRC, TERT, TOP1 |
2.37009 |
[MF] GO:0017171 |
serine hydrolase activity
|
ACHE, F10, F3, MMP1, MMP12, MMP2, MMP9 |
2.31403 |
[MF] GO:0140097 |
None
|
APEX1, POLA1, POLB, TERT, TOP1, TOP2A |
2.29322 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ADORA1, APEX1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, FLT3, HSD17B1, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, IGF1R, KDR, MET, MMP12, PIM1, POLA1, POLB, PPARA, PTPN1, RORC, SRC, TBXAS1, TERT, TOP1, TOP2A, XDH |
2.23155 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, SRC, TOP1 |
2.15617 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, HSD17B1, HSD17B2, XDH |
2.12022 |
[MF] GO:0005158 |
None
|
IGF1R, PTPN1, SRC |
2.00115 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.00115 |